These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4765173)

  • 1. [Effect of Lysenyl on lactation during the puerperium (author's transl)].
    Stríbrný J; Hájek Z; Papez L; Burdová M; Filipovicová M; Rezábek K
    Cesk Gynekol; 1973 Nov; 38(9):688-9. PubMed ID: 4765173
    [No Abstract]   [Full Text] [Related]  

  • 2. [New possibilities of the lactation-arrest in puerperium (author's transl)].
    Vachousek J; Cerný V; Chmelík V; Papez L
    Cesk Gynekol; 1975 Feb; 40(1):50-2. PubMed ID: 1131903
    [No Abstract]   [Full Text] [Related]  

  • 3. [Influence of lisuridhydrogen maleate on prolactin secretion in puerperium].
    Hardt W; Schmidt-Gollwitzer M; Horowski R
    Arch Gynecol; 1979 Jul; 228(1-4):585-6. PubMed ID: 485487
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of Lisuride on serum prolactin levels during puerperium.
    Venturini PL; Maganza C; Massimilla A; Campanella P; Rossato P; Ragni N; De Cecco L
    Acta Eur Fertil; 1979 Jun; 10(2):51-5. PubMed ID: 545976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The treatment of puerperal lactation with bromocriptine.
    Cooke I; Foley M; Lenton E; Preston E; Millar D; Jenkins A; Obiekwe B; McNeilly A; Parsons J; Kennedy G
    Postgrad Med J; 1976; 52suppl 1():75-80. PubMed ID: 959129
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of bromoergocryptine in physiological inhibition of lactation].
    Canales ES; Levinson G; González-Colindres J; de la Peña RO; Zárate A
    Ginecol Obstet Mex; 1975 Feb; 37(220):49-52. PubMed ID: 1123159
    [No Abstract]   [Full Text] [Related]  

  • 7. The suppression of puerperal lactation with bromocriptine.
    O'Donoghue RF
    Ir Med J; 1977 Apr; 70(5):172-3. PubMed ID: 324946
    [No Abstract]   [Full Text] [Related]  

  • 8. [Bromergocriptine for suppression of puerperal lactation].
    Poulsen EF; Nygaard B; Larsen S; Lenstrup C
    Ugeskr Laeger; 1976 Aug; 138(32):1927-9. PubMed ID: 781971
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prevention of postpartum lactation using a new ergot derivative: 2-Br-alpha-ergocryptine or CB-154. Comparison with chlorotrianisene].
    Dexeus Trias de Bes J
    Gynakol Rundsch; 1975; 15(1):91-6. PubMed ID: 1243823
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of methergoline in inhibition of puerperal lactation].
    Iannotta F; Berra G
    Minerva Ginecol; 1979 May; 31(5):399-404. PubMed ID: 572517
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical study on the use of methergoline for the inhibition of lactation during the puerperium].
    Giana M; Dolfin G; Siliquini G
    Minerva Med; 1979 Nov; 70(49):3337-41. PubMed ID: 503350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metergoline as a lactation inhibitor.
    Caballero A; Palomo A; Molina CE; Albarrán FJ; Caballero A; Mena P
    J Reprod Med; 1982 Apr; 27(4):202-6. PubMed ID: 7097670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of lactation in rats with lysenylr SPOFA(N-(D-6-methyl-8-isoergolenyl) N', N'-diethylcarbamide hydrogen maleate).
    Ausková M; Rezábek K; Zikán V; Semonský M
    Endocrinol Exp; 1974 Mar; 8(1):51-8. PubMed ID: 4547705
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of lisuride [N-(D-6-methyl-8-isoergolinyl)-N',N'-diethyl-urea hydrogenmaleate] on reproductive endocrine function of women (author's transl)].
    Okamura T; Miyata R; Taniguchi I; Marumoto Y; Kamiya M; Kaibara M; Kobayashi T
    Acta Obstet Gynaecol Jpn; 1981 Apr; 33(4):489-98. PubMed ID: 6785989
    [No Abstract]   [Full Text] [Related]  

  • 15. [Analogue drugs of ergot-alkaloids with an inhibitory effect upon prolactin secretion and their influence upon the mammary gland (author's transl)].
    Rezábek K; Ausková M; Semonský M
    Cesk Gynekol; 1975 Feb; 40(1):52-3. PubMed ID: 1131904
    [No Abstract]   [Full Text] [Related]  

  • 16. [2-Br-alpha-ergocryptine (Parlodel) in primary and secondary lactation suppression following child-birth or abortion (author's transl)].
    Gehring H; Fischer S; Hofer U
    Schweiz Rundsch Med Prax; 1977 Aug; 66(31):985-9. PubMed ID: 556441
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prolactin levels in the blood-serum of mothers in early puerperium (author's transl)].
    Talas M; Gazárek F; Stehlíková J; Fingerová H; Mohapl M
    Cesk Gynekol; 1975 Feb; 40(1):41-2. PubMed ID: 1131898
    [No Abstract]   [Full Text] [Related]  

  • 18. [Anti-serotonergic drugs in the puerperium: blocking of lactopoiesis with methergoline].
    Torre GC; Chisale E; Vecchiato M; Valle PF; Fazzari D; Grippaldi C
    Riv Ital Ginecol; 1980; 59(4-5):451-8. PubMed ID: 7313405
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of puerperal lactation by metergoline: interactions with methylergobasine maleate.
    Scapin F; Calistri D; Tronconi G; Pellicciotta G; Bareggi SR; Pontiroli AE
    Gynecol Obstet Invest; 1983; 15(3):185-90. PubMed ID: 6682072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of methergoline and of a synthetic estrogen on plasmatic prolactin levels and on postpartum lactation].
    Boemi P; Pace G; Cianci A; Pellicciotta G; Palumbo G
    Minerva Ginecol; 1980 Mar; 32(3):135-42. PubMed ID: 6445525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.